Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

targetedonc.com image

News from targetedonc.com

Top targetedonc.com News

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager
Business · Canada

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager

75% Left coverage: 4 sources
VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease,…See the Story
FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab
FDA · United States

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

The approval of 2 denosumab biosimilars, Bildyos and Bilprevda, enhances access to affordable bone health treatments for patients.See the Story
Zongertinib Receives Breakthrough Therapy Designation for Patients With HER2 Non-Small Cell Lung Cancer
United States · United States

Zongertinib Receives Breakthrough Therapy Designation for Patients With HER2 Non-Small Cell Lung Cancer

Zongertinib promises significant advancements in patient care.See the Story

Breaking News Topics Related to targetedonc.com

Cancer icon

Cancer

Maryland icon

Maryland

Breast Cancer icon

Breast Cancer

Medical icon

Medical

United States icon

United States

News
For You
SearchBlindspotLocal